Inhibition of myostatin in mice improves insulin sensitivity via irisin-mediated cross talk between muscle and adipose tissues

International Journal of Obesity

Volumn 40, Issue 3, 2016, Pages 434-442

  Dong, J ^a,b   Dong, Y ^b,c   Chen, F ^a   Mitch, W E ^b   Zhang, L ^b  

^a SICHUAN UNIVERSITY   (China)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TRANSPORTER 4; IRISIN; MYOSTATIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN KINASE B; SHORT HAIRPIN RNA; INSULIN;

ADIPOSE DERIVED STEM CELL; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY COMPOSITION; BROWN ADIPOSE TISSUE; CELL INFILTRATION; CONTROLLED STUDY; ENERGY EXPENDITURE; FATTY ACID OXIDATION; GLUCOSE TOLERANCE TEST; IMMUNOHISTOCHEMISTRY; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; LIPID DIET; LUNG GAS EXCHANGE; MALE; MOLECULAR INTERACTION; MOUSE; MUSCLE GROWTH; MUSCLE TISSUE; NONHUMAN; OBESITY; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; WHITE ADIPOSE TISSUE; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; DISEASE MODEL; INSULIN RESISTANCE; LIPID METABOLISM; METABOLISM; MOLECULARLY TARGETED THERAPY; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ADIPOSE TISSUE; ANIMALS; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; MALE; MICE; MICE, INBRED C57BL; MOLECULAR TARGETED THERAPY; MUSCLE, SKELETAL; MYOSTATIN; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR CROSS-TALK;

EID: 84960815554     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2015.200     Document Type: Article

References (58)

1. McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997; 387: 83-90.
2. McPherron AC, Lee SJ. Double muscling in cattle due to mutations in the myostatin gene. Proc Natl Acad Sci USA 1997; 94: 12457-12461.
3. Kambadur R, Sharma M, Smith TP, Bass JJ. Mutations in myostatin (GDF8) in double-muscled Belgian Blue and Piedmontese cattle. Genome Res 1997; 7: 910-916.
4. Clop A, Marcq F, Takeda H, Pirottin D, Tordoir X, Bibe B, et al. A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep. Nat Genet 2006; 38: 813-818.
5. Schuelke M, Wagner KR, Stolz LE, Hubner C, Riebel T, Komen W, et al. Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med 2004; 350: 2682-2688.
6. Zhang L, Rajan V, Lin E, Hu Z, Han HQ, Zhou X, et al. Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease. FASEB J 2011; 25: 1653-1663.
7. Lin J, Arnold HB, la-Fera MA, Azain MJ, Hartzell DL, Baile CA. Myostatin knockout in mice increases myogenesis and decreases adipogenesis. Biochem Biophys Res Commun 2002; 291: 701-706.
8. McPherron AC, Lee SJ. Suppression of body fat accumulation in myostatindeficient mice. J Clin Invest 2002; 109: 595-601.
9. Wilkes JJ, Lloyd DJ, Gekakis N. Loss-of-function mutation in myostatin reduces tumor necrosis factor alpha production and protects liver against obesity-induced insulin resistance. Diabetes 2009; 58: 1133-1143.
10. Guo T, Jou W, Chanturiya T, Portas J, Gavrilova O, McPherron AC. Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity. PLoS One 2009; 4: e4937.
11. Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol Rev 2004; 84: 277-359.
12. Walden TB, Hansen IR, Timmons JA, Cannon B, Nedergaard J. Recruited vs. nonrecruited molecular signatures of brown, "brite," and white adipose tissues. Am J Physiol Endocrinol Metab 2012; 302: E19-E31.
13. Wu J, Bostrom P, Sparks LM, Ye L, Choi JH, Giang AH, et al. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell 2012; 150: 366-376.
14. Guerra C, Koza RA, Yamashita H, Walsh K, Kozak LP. Emergence of brown adipocytes in white fat in mice is under genetic control. Effects on body weight and adiposity. J Clin Invest 1998; 102: 412-420.
15. Guerra C, Koza RA, Walsh K, Kurtz DM, Wood PA, Kozak LP. Abnormal nonshivering thermogenesis in mice with inherited defects of fatty acid oxidation. J Clin Invest 1998; 102: 1724-1731.
16. Vegiopoulos A, Muller-Decker K, Strzoda D, Schmitt I, Chichelnitskiy E, Ostertag A, et al. Cyclooxygenase-2 controls energy homeostasis in mice by de novo recruitment of brown adipocytes. Science 2010; 328: 1158-1161.
17. Bostrom P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, et al. A PGC1-Alphadependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 2012; 481: 463-468.
18. Ferrer-Martinez A, Ruiz-Lozano P, Chien KR. Mouse PeP: a novel peroxisomal protein linked to myoblast differentiation and development. Dev Dyn 2002; 224: 154-167.
19. Stanford KI, Goodyear LJ. The therapeutic potential of brown adipose tissue. Hepatobiliary Surg Nutr 2013; 2: 286-287.
20. Harms M, Seale P. Brown and beige fat: development, function and therapeutic potential. Nat Med 2013; 19: 1252-1263.
21. Dong Y, Pan JS, Zhang L. Myostatin suppression of Akirin1 mediates glucocorticoid-induced satellite cell dysfunction. PloS One 2013; 8: e58554.
22. Zhang L, Pan J, Dong Y, Tweardy DJ, Dong Y, Garibotto G, et al. Stat3 activation Links a C/EBPdelta to myostatin pathway to stimulate loss of muscle mass. Cell Metab 2013; 18: 368-379.
23. Zhang L, Du J, Hu Z, Han G, Delafontaine P, Garcia G, et al. IL-6 and serum amyloid A synergy mediates angiotensin II-induced muscle wasting. J Am Soc Nephrol 2009; 20: 604-612.
24. Wang Y, Huang L, Abdelrahim M, Cai Q, Truong A, Bick R, et al. Stanniocalcin-1 suppresses superoxide generation in macrophages through induction of mitochondrial UCP2. J Leukoc Biol 2009; 86: 981-988.
25. Zhou X, Wang JL, Lu J, Song Y, Kwak KS, Jiao Q, et al. Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival. Cell 2010; 142: 531-543.
26. Meng F, Lowell CA. Lipopolysaccharide (LPS)-induced macrophage activation and signal transduction in the absence of Src-family kinases Hck, Fgr, and Lyn. J Exp Med 1997; 185: 1661-1670.
27. Ahima RS. Metabolic actions of adipocyte hormones: focus on adiponectin. Obesity (Silver Spring) 2006; 14: 9S-15S.
28. Lihn AS, Pedersen SB, Richelsen B. Adiponectin: action, regulation and association to insulin sensitivity. Obes Rev 2005; 6: 13-21.
29. Dyck DJ. Adipokines as regulators of muscle metabolism and insulin sensitivity. Appl Physiol Nutr Metab 2009; 34: 396-402.
30. Leibel RL, Hirsch J. Metabolic characterization of obesity. Ann Intern Med 1985; 103: 1000-1002.
31. Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest 2000; 106: 473-481.
32. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444: 860-867.
33. Dong Y, Lakhia R, Thomas SS, Dong Y, Wang XH, Silva KA, et al. Interactions between p-Akt and Smad3 in injured muscles initiate myogenesis or fibrogenesis. Am J Physiol Endocrinol Metab 2013; 305: E367-E375.
34. Sartori R, Milan G, Patron M, Mammucari C, Blaauw B, Abraham R, et al. Smad2 and 3 transcription factors control muscle mass in adulthood. Am J Physiol Cell Physiol 2009; 296: C1248-C1257.
35. Pan DA, Lillioja S, Kriketos AD, Milner MR, Baur LA, Bogardus C, et al. Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 1997; 46: 983-988.
36. Hoppeler H, Howald H, Conley K, Lindstedt SL, Claassen H, Vock P, et al. Endurance training in humans: aerobic capacity and structure of skeletal muscle. J Appl Physiol (1985) 1985; 59: 320-327.
37. Dela F, Larsen JJ, Mikines KJ, Ploug T, Petersen LN, Galbo H. Insulin-stimulated muscle glucose clearance in patients with NIDDM. Effects of one-legged physical training. Diabetes 1995; 44: 1010-1020.
38. Gollnick PD, Saltin B. Significance of skeletal muscle oxidative enzyme enhancement with endurance training. Clin Physiol 1982; 2: 1-12.
39. Akpan I, Goncalves MD, Dhir R, Yin X, Pistilli EE, Bogdanovich S, et al. The effects of a soluble activin type IIB receptor on obesity and insulin sensitivity. Int J Obes (Lond) 2009; 33: 1265-1273.
40. Bernardo BL, Wachtmann TS, Cosgrove PG, Kuhn M, Opsahl AC, Judkins KM, et al. Postnatal PPARdelta activation and myostatin inhibition exert distinct yet complimentary effects on the metabolic profile of obese insulin-resistant mice. PLoS One 2010; 5: e11307.
41. Hamrick MW, Pennington C, Webb CN, Isales CM. Resistance to body fat gain in? double-muscled' mice fed a high-fat diet. Int J Obes (Lond) 2006; 30: 868-870.
42. Kelly DP. Medicine. Irisin, light my fire. Sci 2012; 336: 42-43.
43. Stanford KI, Middelbeek RJ, Townsend KL, An D, Nygaard EB, Hitchcox KM, et al. Brown adipose tissue regulates glucose homeostasis and insulin sensitivity. J Clin Invest 2013; 123: 215-223.
44. Chondronikola M, Volpi E, Borsheim E, Porter C, Annamalai P, Enerback S, et al. Brown adipose tissue improves whole-body glucose homeostasis and insulin sensitivity in humans. Diabetes 2014; 63: 4089-4099.
45. LeBrasseur NK, Schelhorn TM, Bernardo BL, Cosgrove PG, Loria PM, Brown TA. Myostatin inhibition enhances the effects of exercise on performance and metabolic outcomes in aged mice. J Gerontol A Biol Sci Med Sci 2009; 64: 940-948.
46. Murphy KT, Koopman R, Naim T, Leger B, Trieu J, Ibebunjo C, et al. Antibody-Directed myostatin inhibition in 21-mo-old mice reveals novel roles for myostatin signaling in skeletal muscle structure and function. FASEB J 2010; 24: 4433-4442.
47. Zhang C, McFarlane C, Lokireddy S, Bonala S, Ge X, Masuda S, et al. Myostatin-Deficient mice exhibit reduced insulin resistance through activating the AMP-Activated protein kinase signalling pathway. Diabetologia 2011; 54: 1491-1501.
48. Shan T, Liang X, Bi P, Kuang S. Myostatin knockout drives browning of white adipose tissue through activating the AMPK-PGC1alpha-Fndc5 pathway in muscle. FASEB J 2013; 27: 1981-1989.
49. Wang M, Yu H, Kim YS, Bidwell CA, Kuang S. Myostatin facilitates slow and inhibits fast myosin heavy chain expression during myogenic differentiation. Biochem Biophys Res Commun 2012; 426: 83-88.
50. Hennebry A, Berry C, Siriett V, O'Callaghan P, Chau L, Watson T, et al. Myostatin regulates fiber-Type composition of skeletal muscle by regulating MEF2 and MyoD gene expression. Am J Physiol Cell Physiol 2009; 296: C525-C534.
51. Girgenrath S, Song K, Whittemore LA. Loss of myostatin expression alters fibertype distribution and expression of myosin heavy chain isoforms in slow- and fast-Type skeletal muscle. Muscle Nerve 2005; 31: 34-40.
52. Jorgensen SB, Richter EA, Wojtaszewski JF. Role of AMPK in skeletal muscle metabolic regulation and adaptation in relation to exercise. J Physiol 2006; 574/Pt 1: 17-31.
53. Yadav H, Rane SG. TGF-beta/Smad3 Signaling Regulates Brown Adipocyte Induction in White Adipose Tissue. Front Endocrinol (Lausanne) 2012; 3: 35.
54. Fournier B, Murray B, Gutzwiller S, Marcaletti S, Marcellin D, Bergling S, et al. Blockade of the activin receptor IIb activates functional brown adipogenesis and thermogenesis by inducing mitochondrial oxidative metabolism. Mol Cell Biol 2012; 32: 2871-2879.
55. Yadav H, Quijano C, Kamaraju AK, Gavrilova O, Malek R, Chen W, et al. Protection from obesity and diabetes by blockade of TGF-beta/Smad3 signaling. Cell Metab 2011; 14: 67-79.
56. Tseng YH, Kokkotou E, Schulz TJ, Huang TL, Winnay JN, Taniguchi CM, et al. New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure. Nature 2008; 454: 1000-1004.
57. Schulz TJ, Huang TL, Tran TT, Zhang H, Townsend KL, Shadrach JL, et al. Identification of inducible brown adipocyte progenitors residing in skeletal muscle and white fat. Proc Natl Acad Sci USA 2011; 108: 143-148.
58. Koncarevic A, Kajimura S, Cornwall-Brady M, Andreucci A, Pullen A, Sako D, et al. A novel therapeutic approach to treating obesity through modulation of TGFbeta signaling. Endocrinology 2012; 153: 3133-3146.